Corcept Therapeutics Inc (CORT)
Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell
$33.51
Buy
$33.88
$0.59 (+1.77%)
Prices updated at 20 Jul 2024, 00:58 EDT
| Prices minimum 15 mins delay
Prices in USD
Corcept Therapeutics Inc is engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders by modulating the effects of cortisol.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
In the news
Sharecast service unavailable
Press releases
Key dates
Forecast date | |
---|---|
Annual general meeting | May 2025 |
Annual report | Feb 2025 |
Final results | Feb 2025 |
Half yearly results | Aug 2024 |
Previous date | |
---|---|
Annual general meeting | May 2024 |
Annual report | Feb 2024 |
Final results | Feb 2024 |
Half yearly results | Aug 2023 |
Company reports
31 Dec 2023
Annual Report 30 Sep 2023
Quarterly Report